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Objective: This study assessed the effect of increased dietary protein intake on adaptation of 
energy expenditure and skeletal muscle function at rest and during low-intensity physical activity 
in elderly adults. 
Methods: Using a randomized, crossover design, 12 adults (7 F, 5 M), aged 82  7 y (mean  
SD) completed two 6-day periods of consuming fruit-smoothie beverages twice daily (with 
breakfast and lunch) containing 230 kcal and 25 g whey protein (WPro) or 25 g corn-derived 
glucose polymer (CHO) (total 460 kcal/day and 50 g/day WPro or CHO). 
Results: On day 7 of each period, fasting blood urea nitrogen was 28  9% higher in WPro vs. 
CHO (P=0.003), consistent with higher total protein intake. Fasting state energy expenditure and 
respiratory ratio at rest and while exercising on a stationary cycle at 1, 10, 20 watts were not 
different between WPro and CHO. Gross mechanical efficiency of skeletal muscle progressively 
increased from 1 to 10 to 20 watts, but this response was not different between WPro and CHO. 
Conclusion: Short-term supplementation with either whey protein or glucose polymer does not 
differentially influence fasting state whole body substrate utilization or skeletal muscle work 
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LITERATURE AND RATIONALE 
 
 From previous research we know protein is critical for maintaining muscle size and 
function [3, 18]. This is particularly relevant for old adults who experience a progressive decline 
in muscle mass, referred to as sarcopenia. Old adults also experience a decline in substrate 
utilization [1, 3, 5, 18, 20].  One way of measuring substrate utilization is through oxygen 
consumption at rest and during low levels of exercise [7, 11, 14]. At low levels of exercise, 
measuring the volume of oxygen consumed (VO2) presupposes a change in pulmonary VO2 
predicts changes in muscular VO2 [4, 7, 13, 14].  
Other predictors of muscle function besides substrate utilization as measured by VO2, 
include balance and gait. Physiological declines of aging, including sarcopenia, are factors in 
decreased balance, gait speed, and stride length [17]. All of these factors are well-researched due 
to their correlation with fall risk in the elderly [17, 21].  





) caused a down-regulation of 35 of 38 gene transcript profiles involved with energy 
metabolism in skeletal muscle in old adults [18], compared to when they consumed an iso-









groups protein intakes. Decreased transcripts from inadequate protein intakes imply an adaptive 
response in muscle by an increase in the efficiency of substrate utilization to preserve muscle 
function. This adaptive response would precede physiological changes of accommodation such 
as muscle wasting [18].  
Consumption of an energy restricting diet lead to increased skeletal muscle efficiency in 
a 2003 study of weight perturbation and the effects of muscle function [14]. The energy 




decrease in protein intake as a component of the cause for an increase in skeletal muscle 
efficiency. This increase is muscle efficiency accounts for decreased non-resting energy 
expenditure associated with energy restriction, demonstrating an adaptive change in skeletal 
muscle. Muscle efficiency in this study was quantified by Gross Mechanical Efficiency which is 
defined as the ratio of power generated to the change in energy expenditure above resting [14].  
Low levels of physical activity were used to calculate GME in this study to account for the 
sedentary lifestyles of their subjects.  
The primary aim of our study was to investigate the effects of short-term increases in 
dietary protein on adaptive changes in skeletal muscle, such as the efficiency of substrate 
utilization in old adults. From previous research mentioned above we know decreasing protein 




will lead to changes in muscle transcripts. We hypothesize we will also see an 
adaptive change in the efficiency of substrate utilization. Also from past studies mentioned 
above, we know weight loss will lead to increased efficiency of substrate utilization in skeletal 
muscle. Old adults are in a comparable state to weight loss populations because both involve the 
loss of muscle mass [16]. We also hypothesize that increased protein intake in old adults will 
lead to decreased muscle efficiency of substrate utilization.  
Our secondary aim was to evaluate other indicators of muscle function such as gait speed 
and balance. We hypothesize that there will be no effect of protein supplementation on gait and 
balance, since we will use a short term dietary intervention. 
In this study, we measured substrate utilization efficiency in skeletal muscle in twelve 
elderly volunteers (7F, 5M) following 6 days of protein and carbohydrate supplementation. Low 
levels of exercise were selected to represent the sedentary lifestyle of older individuals. Their 






 Potential volunteers were recruited from University Place Retirement Community in 
West Lafayette, Indiana. All participants obtained physician approval prior to starting the study. 
The exclusion criteria for the study are listed below: 
-  Diagnosis of diabetes mellitus. 
- Status post myocardial infarction (MI) or coronary artery bypass graft (CABG) or 
percutaneous transluminal coronary angioplasty (PTCA) within 6 months and/or a 
documented ejection fraction of less than 50% . 
- Acute upper respiratory infection. 
- Acute symptoms suggestive of cardiovascular disease. 
-  Acute symptoms suggestive of acute congestive heart failure. 
-  Uncontrolled hypertension at rest (systolic blood pressure greater than or equal to 
160 mm Hg and or diastolic blood pressure greater than or equal to 100 mm Hg). 
-  Lower extremity conditions (such as osteoarthritis or peripheral vascular disease), 
which preclude the subject from peddling a stationary cycle at 20 watts. 
-  Cognitive conditions or limitations that preclude the subject from being able to 
understand, comprehend, or interpret instructions, fatigue or symptoms. 
- Routine use of supplemental oxygen during rest or exercise. 
 
 Volunteer characteristics are included in Table 2. Twelve volunteers completed the study, 
seven female and five male. 
 All study procedures were approved by the Purdue University Biomedical Institutional 




risks of the study prior to signing the informed consent document. There was no monetary 




 We utilized a randomized, cross-over design for this study (Figure 1). Each volunteer was 
tested following two six-day interventions. Between each intervention there was a 7-day washout 
period where volunteers returned to their normal diet with no supplementation. During the last 
three days of each intervention volunteers recorded all dietary intake on dietary record forms 
which were reviewed by a research assistant on test day to ensure completion.  
 There were two test days on study day 7 and day 21.  On each test day, volunteers arrived 
in the morning having been fasted overnight for at least 8 hours. Testing lasted approximately 3 
hours and included resting and non-resting energy expenditure, gait, balance, a blood draw, and 
body composition measurements. Before exercise protocol, volunteers completed a readiness to 
exercise questionnaire (Par-Q Survey) to ensure there were no medical changes recently that 
would prevent them from performing the exercise safely. 
 All test day procedures were explained and practiced by the volunteers prior to beginning 
the study to allow for equipment acclimation. 




















































Smoothie Mix 1 Smoothie Mix 2 
FIGURE 1. Clinical phase timeline. Test days are on study day 7 and day 21 following a 
randomized cross-over design of treatments that lasted 6 days each. The washout period had 









 Volunteers were provided shake supplements to consume twice daily, once at breakfast 
and once at lunch during each of the interventions. Each supplement contained 230 kcal of 
energy from mixtures of carbohydrates, fat, and protein (total energy per day was 460 kcal). The 
two interventions had different supplements, given in a random crossover design, that differed in 
the amounts of macronutrients, but not total energy (Table 1). One supplement was the placebo, 
which contained 22 grams of polydextrose, a corn derived glucose polymer (CHO). The other 
supplement was the high-protein supplement, which contained 22 grams of whey protein 
(WPro). Both supplements contained the same amount of fat.  
 
Table 1. Total Macronutrient Composition Smoothies During WPro and CHO 
interventions  
   
  WPro Smoothie CHO Smoothie Mix   










Each smoothie was consumed twice daily during each intervention. Values reported above include 22 
grams of added whey protein or polydextrose. 
 
 Volunteers were given the supplements frozen and pre-prepared prior to the start of each 
intervention. Volunteers were instructed to keep the smoothies frozen until the consumption of 
each one. All volunteers were also instructed to consume the smoothies with breakfast and lunch 
meals, and were told to compensate within their normal diet to account for the smoothies to 
achieve satiation at each meal time. 
 During each treatment volunteers completed dietary records during the last three days 
prior to testing day. This allowed for dietary acclimation for the addition of the supplement. The 
results of the dietary records were analyzed using the Nutritional Data System for Research 




(kcal), total protein intake (g), and total carbohydrate intake (g) during WPro and CHO 
interventions, as well as pre-study for each volunteer.  
  
Resting Energy Expenditure 
 Volunteers were rested and acclimated to room temperature for at least thirty minutes 
prior to testing. A neoprene hood was placed over the subject's head and resting energy 
expenditure was measured using indirect calorimetry for thirty minutes. We utilized a TrueOne  
2400 Metabolic Measurement System by Parvo Medics (Sandy, Utah, U.S.A.) to measure O2 and 
CO2. The last twenty minutes of data were used for analysis to provide acclimation time for the 
volunteer during the first ten minutes. 
 
Blood 
 A fasting blood sample was obtained from an antecubital vein after the volunteer had 
rested in a seated position for 15 minutes to obtain a clinical chemistry panel, pre-albumin and 
complete blood count with differential.  
 
Non-Resting Energy Expenditure  
 Fasting non-resting energy expenditure was recorded during a low level cycle egrometer 
protocol using indirect calorimetry during each test day. We utilized a TrueOne  2400 
Metabolic Measurement System by Parvo Medics (Sandy, Utah, U.S.A.) to measure O2 and CO2, 
which was also used in resting energy expenditure. 
 During this test, the volunteer wore a plastic headpiece, which had a rubber mouthpiece 




the pneumotach. The analyzer module measured gas composition from the pneumotach and 
processed it to the computer.  
 Exercise protocol was low resistance to represent the sedentary lifestyle of most old 
adults. Volume of oxygen consumed and CO2 produced were recorded and energy expenditure 
was estimated using the Weir Equation [7]. 
 To begin the test, the volunteer began by cycling for 2 minutes at 0 watts (no resistance 
on the peddles) for a warm up. Volunteers continued peddling at 1 watt for an additional four 
minutes after the warm up. The next stage was 10 watts of power for four minutes, followed by 
the last stage of 20 watts of power for an additional four minutes of peddling. Finally, there was 
a two-minute cool down period at 0 watts again. The entire test lasted 16 minutes, and data were 
collected for analysis during the last three minutes of each stage of power (1, 10 and 20 watts). 
During pre-study, while the volunteers were acclimated to the cycle they were instructed to find 
a comfortable pace, or rotations per minute (rpm), for peddling. The rpm they selected was 
recorded and on both test days volunteers were monitored by a research assistant to ensure they 
peddled at this same pace.  
 
Gait  
 Volunteers were instructed to walk at a normal pace over a pressure-sensing walkway, 
the GAITRite® system by CIR Systems Inc (Clifton, NJ) . The GAITRite® measured temporal 
and spatial gait parameters such as step length, step width, and gait speed at a frequency of 80 Hz 
and transferred data to a computer with GAITRite® Gold, Version 3.4 software. The volunteer 
had at least twenty-five footsteps recorded by the GAITRite® during test days. Means for stride 









 Standing balance was assessed using the Biodex Balance System SDTM by Biodex 
Medical Systems, Inc. (Shirley, NY). Three 20 second trials were performed with the volunteer 
standing on a steady platform force plate on each test day. The average of the three trials was 
reported by the machine in three parameters: overall stability index, anterior-posterior balance, 
and medial-lateral balance. These indices were then recorded onto a computer for each volunteer. 
 
Body Composition 
 Body composition measurements were made in the fasting state on testing days using a 
bioelectric impedance machine which recorded weight (kg), and percent body fat (%). Fat-free 
mass (FFM) was calculated from weight and percent body fat for each volunteer as well. 
 
Calculations 
 Gross mechanical efficiency (GME) calculations were performed using non-resting 
energy expenditure (NREE) and resting energy expenditure (REE) data [14]. REE was 
subtracted from NREE (on the cycle egrometer). NREE and REE were corrected for by the ratio 
of oxygen consumption and carbon dioxide expiration, or the respiratory exchange ratio (RER), 
of each volunteer during rest and each workload. This determined the amount of energy being 
expended per minute of cycling. The power generated during cycling at 1, 10, and 20 Watts was 
converted to kilocalories (kcal) per minute by the equation 1 W = 0.01433 kcal/min. GME was 
then calculated as the ratio of power generated in kcal/minute to the change in energy 








 Statistical analysis were preformed using SPSS. Values are reported as means  standard 
deviations in tables and means  standard error of the mean in figures. All measured outcomes 
were analyzed by a repeated measures analysis between treatments.  Statistical significance was 







 Volunteer characteristics are presented in Table 2 below. During the study percent body 
fat and weight did not change across treatments from pre-study measurements.  
 
 
Effect of Carbohydrate and Protein Intervention on Diet and Blood 
 Volunteers consumed the same amount of total energy during WPro and CHO 
interventions (Table 3). However, volunteers consumed significantly less energy during pre-
study measurements. 
 
Table 3. Energy Intake Changes Associated With WPro and CHO Interventions 
 Pre-Study WPro CHO 
Energy intake (kcal d
-1 
)  1658 ±  367 
a 
1945 ±  394 
b 







) 0.95 ± 0.24 
a
 1.63 ± 0.25 
b







) 3.12 ± 0.61 
a
 3.42 ± 0.72 
a
 3.83 ± 1.40 
b
 
Superscripts that vary in letters are significantly different (p  0.05).  
 
 
Table 2. Pre-Study Volunteer Characteristics 
Age, years 82 ± 7 
Weight, kg 72.14 ± 11.23 
Percent Body Fat, % 33.28 ± 8.76 
Fat-Free Mass, kg 48.16 ± 9.73 
Resting Energy Expenditure, kcal/min, kcal/day 0.850 ± 0.149 (1223 ± 214) 




 Total protein intake was higher during the WPro intervention versus the CHO 
intervention and pre-study measurements. The difference in average protein intake between 





  Total carbohydrate intake was higher during the CHO intervention compared to the WPro 
intervention and pre-study measurements. During the CHO intervention volunteers were 




more carbohydrates then during the WPro intervention.  
 The reported change in total protein intake during each of the treatments is supported by 
the change in blood urea nitrogen (Figure 2). The WPro group had a 28% higher blood urea 























FIGURE 2. Blood urea nitrogen during the WPro and CHO interventions. Values are reported as 
mean ± standard error of the mean. Superscripts that vary in letters are significantly different (p-
value  0.05). 
 
 Pre-albumin concentration was not different between treatments (p  0.05). Pre-albumin 
was 25.5 ± 3.0 mg/dL for the WPro group and 24.9 ± 3.7 mg/dL for the CHO treatment. 
 
20.12  1.12 a 
25.88  1.62 b 































Effect of Protein Intervention on Substrate Utilization 
 The figure below represents the percent of fat, carbohydrate, and estimated protein 
utilized during resting and cycling protocol (Figure 3). At rest volunteers were utilizing 64.2% 
and 58.0% fat and 21.8% and 28.0% carbohydrate during WPro and CHO treatments 
respectively. Fat and carbohydrate utilization was not significantly different between treatments.  
 
FIGURE 3. Macronutrient utilization during the WPro and CHO interventions at rest and at low 
levels of exercise. Percentages were determined from respiratory quotient (RQ) from indirect 
calorimetry. 
 
   
 During exercise, fat utilization decreased from 1, to 10, to 20 watts, and carbohydrate 
utilization increased, these responses were not different between WPro and CHO.  
 It should be noted that our methods did not allow for accurate calculations of protein  
utilization. Therefore, protein utilization was set at 14% for both interventions at rest and during 
14.0 14.0 14.0 14.0 14.0 14.0 14.0 14.0 
21.8 
28.0 
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exercise. Previous research in our lab has determined this to be a reasonable assumption for 
protein utilization. 
 
Effect of Protein Intervention on Muscle Efficiency 
 GME increased from 1, to 10, to 20 watts indicating an exercise response. This response 
was not different between WPro and CHO interventions. 
 
 
FIGURE 4. Gross Mechanical Efficiency (GME) during the WPro and CHO interventions. Values 
are reported as mean ± standard error of the mean. There were no significant changes between 
treatments (p-value  0.05).  
 
 
Effect of Protein Intervention on Gait and Balance 
 Overall stability index showed no significant differences between treatments (Table 4). 
anterior-posterior balance and medial-lateral balance were not significantly changed between 









































Table 4. Balance Index between WPro and CHO Treatments 
   
  Overall stability index  
Anterior-posterior 
balance  Medial-lateral balance  
WPro  0.725 ± 0.230 0.408 ± 0.131 0.458 ± 0.207 
CHO 0.692 ± 0.264 0.392 ± 0.173 0.467 ± 0.206 
All values are expressed as mean ± standard deviation. There were no significant differences between 




 Supplementation with WPro or CHO did not influence gait characteristics including time 
in double support and stride length in either foot. Gait speed and cadence did not show 
significant differences between treatments either (Table 5).  
 
Table 5. Gait Characteristics between WPro and CHO Treatments 
 
 WPro CHO 
 
Right Foot Left Foot Right Foot Left Foot 
Double Support 
(sec) 0. 36 ± 0.08 0.36 ± 0.08 0.33 ± 0.08 0.33 ± 0.08 
Stride Length 
(cm) 108.83 ± 20.61 108.37 ± 20.68 112.36 ± 21.91 111.83 ± 22.34 
 
Cadence 
(steps/min) 110.65 ± 10.76 113.66 ± 12.07 
Gait Speed (cm/s)  100.19 ± 23.39 106.36 ± 25.65 
All values are expressed as mean ± standard deviation. There were no significant differences between 











 The first aim of this study was to investigate the effects of supplementation of protein or 
carbohydrate on efficiency of substrate utilization in skeletal muscle. We know that inadequate 
intakes of protein, or energy restriction accompanied by protein restriction, will increase 
efficiency [14, 18]. Using this information, we had hypothesized that efficiency would decrease 
with an increase of dietary protein. This study found no evidence of protein supplementation 
affecting the efficiency of substrate utilization as measured by gross mechanical efficiency 
compared to carbohydrate supplementation.  
 Previous research has identified adaptive changes in muscle transcript levels involved 




). We had 
expected to see changes from an opposite effect of high protein as well [18]. The lack of the 
adaptive response indicates short term protein supplementation may not elicit adaptive changes 
in muscle, and therefore may have no effect on long term physiological outcomes of 
accommodation. In contrast, in short-term inadequate protein intake diets, adaptation markers are 
evident and precede accommodation responses of muscle wasting [18].  
 Our secondary aim was that protein supplementation would not affect gait or balance 
characteristics of our volunteers. Gait data such as stride length, time in double support, cadence, 
and gait speed were not altered between interventions, nor were balance indices. These responses 
were predicted because gait and balance are long term indicators of muscle function and would 
most likely not be influenced by short term supplementation.  
 This study was unique because it investigated short-term high protein intakes for elderly 




) and subsequent muscle outcomes. Previous research focused on energy or 




and its effect on muscle function. Since dietary protein is so critical in maintaining muscle size 
and function, research focused on supplementation is also necessary for old populations.  
 This study was also novel because it investigated muscle efficiency at very low powered 
stationary cycle ergometry. Rosebaum et at in 2003, found that changes in muscle work 
efficiency are most prevalent at low levels of physical activity [14].  Also, this study reported 
that using a cycle ergometer can be a surrogate for activities of daily living [14]. Their subjects 
were not comparable in age to ours, but they were confined to a research facility and considered 
sedentary.  A sub-maximal test, as used in previous research on muscle function in old people 
may not be appropriate. Utilizing low powered exercise such as in the present study may be more 
representative of the activities of daily living of old people. 
 This study was limited in statistical power due to the small number of subjects that 
participated. This study was also limited because it was not a complete dietary intervention, 
rather just a supplementation. Our results show increases in total energy intake during 
supplementation from pre-study measurements due to lack of complete compensation. We know 
from previous research that increases in energy intake will influence resting and non-resting 
energy expenditure, so it is important to keep volunteers on an iso-caloric diet while 
manipulating their protein and carbohydrate intake [14].  
 Future research should be aimed at investigating the effects of protein supplementation 
for longer interventions in elderly adults. It would be especially important for a longer 
intervention to have maintained weight of volunteers by having them consume an iso-caloric diet 
as mentioned above. Also future research should focus on comparing inadequate versus 
supplemental protein intakes. The present study included a group with supplemental protein 












). Since we know inadequate protein leads to adaptive changes in muscle, having 
a low protein group could serve as a control for the protein supplemented group. 
 In conclusion, the present study represented two groups of elderly individuals who 
consumed short-term diets of adequate protein intakes, and high protein intakes. No adaptive 
changes in muscle occurred between high protein (WPro) or adequate protein (CHO) intakes as 
measured by substrate utilization at rest and during exercise. The exercise protocol was low 
intensity, which represented activities of daily living for old people. This could be indicative that 
supplementation of protein to already adequate protein intakes may not elicit any later changes of 
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Men and Woman Age 65 and Older 
Needed For Research Study 
Dr. Wayne Campbell in the Department of Nutrition Science, 
Stone Hall, Purdue University, West Lafayette, IN is 
conducting a research study to assess diet and muscle 
function in adults 65 years and older. This study will be 
conducted at University Place Senior Living Community. 
This study includes 2 parts, over a period of 26 days. 
Part 1 of this study will last approximately 5 Days with 1 Test Day 
Part 1 and 2 of this study will last approximately 26 Days with 3 Test Days 
Measurements Will Include: 
 Resting Energy Expenditure 
 Exercise Energy Expenditure (Stationary Bike Exercise) 
 Body Composition(lean and non-lean body tissue) 
 Blood Chemistry Profile 
 Diet Analysis 
 Physical Energy Level Questionnaires  
 You Will Be Asked To Consume A Dietary Supplement In 
Part 2 
Are you 65 or older and in general good health, non-smoking, do 
not have diabetes, or acute heart or lung diseases? Are you 
physically able to ride on a stationary bike at an easy pace for up 
to 16 minutes? If so, please contact: 
 
Kristen Clark at clarkk@purdue.edu Or  
















RESEARCH PARTICIPANT SCREENING 
CONSENT FORM 
 
Diet and Muscle Function in Older Adults 
 
Professor Wayne W. Campbell, Ph.D. 
Purdue University 
Department of Nutrition Science 
 
Purpose of Research 
The purpose of this study is to assess if your diet, body composition, and physical 
abilities affect how many calories your body burns at rest and while doing low-intensity 
exercise. 
 
Specific Procedures  
The information you will provide during screening may also be used for the study. You 
have been asked to fill out a Medical History Questionnaire and give your doctor a form 
to send back to us that determines your eligibility. You will then return that information 
back to the Department of Nutrition Science at Purdue University. We will then schedule 
a meeting to review your information and describe the study in detail. Once you have a 
good understanding of what we are asking you to do and if you agree, then we can start 
the study.  
 
Screening measurements: # OF DAYS: 1 TOTAL ESTIMATED TIME: ~ 1 hour 
 
Medical History Questionnaire, Physician’s Clearance Form: 
You have provided (to the best of your knowledge) a complete history of all of your 
medical disorders during the screening process.  To the best of your knowledge, you are 
free from disease that might make participation in this study unsafe.  You will let 
Professor Campbell know all of the medications, drugs, and/or supplements that you 
currently take.  You have also provided your physician’s clearance form allowing you to 
participate in this study.  If requested by Professor Campbell, you will agree to stop taking 
some or all of these medications, drugs, and/or supplements two weeks before and 
during this study.  You will not be asked or required to change any of your 
prescription drug intake without the authorization of your personal physician.  It is 
expected that you will not take any new medications, drugs, and/or supplements during 
this study.  It is expected that you will not change the dose of medications that you keep 
taking during the study.  If you find that you must change the dose of your medications, 
you will contact Professor Campbell before the medication change or as soon as possible 
immediately afterward. 
 
Duration of Participation 
Screening procedures will take approximately 1 hour to complete. 
 
Benefits to the Individual 
There is no direct benefit for participating in this study. However, you may benefit from 






Risks to the Individual 
There are no known risks when completing questionnaires. There is a risk of breach of 




You will not be paid for completing this screening process. 
 
Injury or Illness  
Purdue University will not provide medical treatment or financial compensation if you 
are injured or become ill as a result of participating in this research project. This does 




The project's research records may be reviewed by the Purdue University Institutional 
Review Board, Office of Human Research Protections, and by departments at Purdue 
University responsible for regulatory and research oversight. All records will be kept 
confidential in locked cabinets/rooms for at least three years and after the close of the 
study. The data will be kept indefinitely and may be used for future studies. All records, 
data, and specimen will only be available to the principle investigator or his designee for 
analysis purposes.   
 
Voluntary Nature of Participation 
You do not have to participate in this screening evaluation.  If you agree to participate 
you can withdraw your participation at any time without penalty. 
 
Contact Information 
If you have any questions about this research project, you can contact Professor Wayne 
W. Campbell at (765) 494-8236.  If you have concerns about the treatment of research 
participants, you can contact the Institutional Review Board at Purdue University, Ernest 
C. Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114.  The 
phone number for the Board is (765) 494-5942.  The email address is irb@purdue.edu
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Documentation of Informed Consent 
I HAVE HAD THE OPPORTUNITY TO READ THIS PARTICIPANT SCREENING 
CONSENT FORM AND HAVE THE RESEARCH STUDY EXPLAINED.  I HAVE HAD 
THE OPPORTUNITY TO ASK QUESTIONS ABOUT THE RESEARCH PROJECT AND 
MY QUESTIONS HAVE BEEN ANSWERED.  I AM PREPARED TO PARTICIPATE IN 
THE SCREENING EVALUATION FOR THE RESEARCH PROJECT DESCRIBED 
ABOVE.  I WILL RECEIVE A COPY OF THIS CONSENT FORM AFTER I SIGN IT.   
 
_________________________________                            _______________ 
            Screening-Participant’s Signature                                                     Date 
  
_________________________________                        _______________ 
                      Researcher’s Signature                                                            Date 
 
Please check only one of the two boxes below 
 
 
You agree to allow the use of your data and/or specimens collected during this 
screening evaluation to be used for future research that is unrelated to this study. 
 
_________________________________                                  _______________ 
            Screening-Participant’s Signature                                                  Date 
 
          
You request your data and/or specimens collected during this screening evaluation 
to NOT be used for any future research that is unrelated to this study. 
 
_________________________________                                    _______________ 
















RESEARCH PARTICIPANT STUDY CONSENT FORM 
Diet and Muscle Function in Older Adults 
 
Wayne W. Campbell, Ph.D. 
Purdue University 
Department of Nutrition Science 
 
Purpose of Research  
This is a two-part project to improve our scientific understanding of diet, body composition 
and energy use in older adults. Part 1 will assess if your diet, body composition, and physical 
abilities affect how many calories your body burns at rest and while doing low-intensity 
exercise. Part 2 will assess how dietary protein intake affects muscle energy use and your 
daily perceived vigor. 
 
Medical History Questionnaire, Physician’s Clearance Form 
You have provided (to the best of your knowledge) a complete history of all of your medical 
disorders during the screening process.  To the best of your knowledge, you are free from 
disease that might make participation in this study unsafe.  You will let Professor Campbell 
know all of the medications, drugs, and/or supplements that you currently take.  You have 
also provided your physician’s clearance form allowing you to participate in this study.  If 
requested by Professor Campbell, you will agree to stop taking some or all of these 
medications, drugs, and/or supplements two weeks before and during this study.  You will not 
be asked or required to change any of your prescription drug intake without the authorization 
of your personal physician.  It is expected that you will not take any new medications, drugs, 
and/or supplements during this study.  It is expected that you will not change the dose of 
medications that you keep taking during the study.  If you find that you must change the dose 
of your medications or a new medication, you will contact Professor Campbell before the 
medication change or as soon as possible immediately afterward. 
 
Procedures To Be Used 
This study includes two parts. Part 1 is shown on the study table (next page) as study days 
one through five (1-5). Part 2 will consist of days 6-26 on the study table below. 
After participating in Part 1, if you are interested in continuing with our research study, you 
can participate in Part 2.  
 
 Part 1                  
 
Part 2 
Description Day  
  0 
Day 



















Screening  X           
Study and Equipment 
Review 
 X          
Diet Supplement     X X   X X  
Wash out Period        X    
Body Composition    X   X    X 
Blood Sample    X   X    X 
Energy Expenditure    X   X    X 
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Bicycle Test     X   X    X 
Physical Ability Test    X   X    X 
Dietary Records   X   X    X  
Energy Level Survey   X   X    X  
Part 1: The study will consist of one test day. Prior to the test day, you will be asked to record 
everything you eat, how it was prepared, and the quantity consumed throughout the days on 
a 3-Day food record sheet, which will be provided. Also during these three days, you will be 
asked to complete an energy-level survey with each meal. This survey will have you rate 
your daily perceived energy level.  
 
Part 2: You will continue to consume your normal diet with the addition of a daily nutritional 
supplement.  At the beginning of the supplementation, you will be asked by our research 
team to consume 2 supplements/day. One will be consumed at the first eating occasion of 
the day (i.e., breakfast) and the second one will be consumed at the second eating occasion 
of the day (i.e., lunch).  You will be asked to consume these supplements for two 6-day 
interventions (total of 12 days). Between these interventions, there will be a washout period 
of no supplements to be consumed lasting from Day 13-19. The supplements will be 
composed of dietary carbohydrates, protein and fat (total of 500calories/day). The 
supplements for each intervention will differ in the amount of protein, consisting of either a 
high protein or low protein shake.  
 
During these interventions, on the last three days you will be asked to record everything you 
eat, how it was prepared, and the quantity consumed throughout the days on a 3-Day food 
record sheet provided. Also during these last three days both interventions you will be asked 
to complete an energy-level survey with each meal. This survey will have you rate your daily 
perceived energy level. 
 
Test Days 
Test days include days 5, 12, and 26. All three of these test days will be identical. Each test 
day will last approximately 3.5 hours. You will need to be in a fasted state. You will be asked 
questions about any recent changes in your health. You will also be asked to complete the 
following tests conducted by a member of our research staff:  
 
A. Body Composition:  
Your height and weight will be measured. The amount of lean to non-lean tissue will 
be determined by stepping on a scale for about 10-15 seconds while barefoot. You 
may hold on to handle bars for balance.  
B. Blood sample:  
You will have about 4 teaspoons of blood drawn from a vein in the crook of your arm 
using a needle. The sample will be used to measure clinical indicators of your health, 
including liver and kidney functions, risk of diabetes, acute illness, and if your body 
has adequate protein. 
C. Energy Expenditure:  
You will lie on a bed in a reclining position for a total of 60 minutes.  During the first 
30 minutes, no measurements will be taken and you will simply lie quietly and relax.  
After 30 minutes, a large clear plastic hood will be placed over your head and the 
amount of oxygen you breathe in and out will be measured for the next 30 minutes.  
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You will be able to breathe normal room air, which is continually flowing into the 
hood during the procedure. This test is used to measure how many calories of 
energy you are burning while resting. 
D. Bicycle Test:  
This test measures how many calories you are using during easy-paced exercise on 
the stationary bike. You will pedal for approximately 16 minutes including a warm up 
and cool down session. During the test, a plastic headset will be worn to hold the 
mouthpiece and tubes for the air measurements. You will breathe through a 
mouthpiece attached to plastic tubes. Room air will always flow through the tubes. We 
will measure how fast and how much air you are taking in and breathing out. 
Periodically, you will be asked to rate how hard you are exercising. A heart rate 
monitor will be used to measure your heart rate before, during, and after exercise.  
 
After the bicycle test, you will receive a snack and beverage before continuing with 
any further testing.  
E. Physical Ability Tests:  
 A series of tests will be done to determine your physical abilities.  
 
Postural Stability 
You will simply be required to fit a square object through an opening of varying size 




You will walk across a pressure-sensing walkway. The GaitRight measures gait 
parameters such as step length, step width, and gait speed. 
 
There is a hierarchy of gait tasks.  In the first level, you will be seated.  In the second 
level, you will walk over a walkway with no obstacles. In the third level, obstacles will 
be placed on the walkway where you must step over and continue walking.  In the 
fourth level, you will walk and step over obstacles while carrying a tray with four 
plastic cups.     
 
F. Dietary Food Record:  
A member of Prof. Campbell’s research staff will review your 3-Day food records with 
you to make sure the information is complete and accurate. 
 
Duration of Participation  
The study will take a minimum of 5 days to complete, but may take longer depending on your 
availability for testing for Part 1. If you participate in Part 1 and Part 2, the study will take a 
minimum of 26 days to complete, but may take longer depending on your availability for 
testing. 
 
Benefits to the Individual 
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There is no direct benefit of participating in this study. However, you may perceive a benefit 




Risks to the Individual 
The following risks exist: 
 Blood Draw  
You may experience discomfort and the development of a small bruise and/or 
infection at the puncture site on your arm where the blood is drawn. You may also 
feel lightheaded and there is a slight risk of fainting. The amount of blood drawn is 
about four (4) teaspoons (two-thirds of a fluid ounce or 20 milliliters) and is small 
enough that it should present no hazard to your physical well-being. 
 Energy expenditure  
There is a risk of a feeling of claustrophobia occurring when clear plastic hood is 
placed over your head. If this occurs, you can always remove the hood or signal 
to the attendant and he or she will remove it for you.  
 Bicycle Testing 
The cycling exercise should feel easy to moderately hard.  During exercise, we 
will monitor your heart rate and stop the test at any time if your heart rate goes 
above an acceptable level for submaximal exercise based on age. If you feel 
discomfort, you can stop peddling at any time during the test. The bicycle seat 
could potentially be uncomfortable as well. Risks include shortness of breath, 
uncomfortable fit of mouthpiece, muscle and joint soreness, cardiac arrest, or 
death. Qualified responders will be on hand to provide assistance if the need 
arises.  
 Functionality Tests: 
There is a risk of falling. If you should feel any discomfort, fatigue, 
lightheadedness, or chest pains the tests can be stopped. 
 Supplement (Part 2 only): 
You may experience some gastro-intestinal discomfort with the supplement used 
in the study.  
  
There is risk of breach of confidentiality. There are no known risks associated with: 
weight and height measurements, fat body tissue measurements and completing 
questionnaires and surveys. 
 
Compensation 
You will not be paid any money for doing this research study. 
 
Injury or Illness  
Purdue University will not provide medical treatment or financial compensation if you are 
injured or become ill as a result of participating in this research project.  This does not 





The project's research records may be reviewed by the Purdue University Institutional 
Review Board, Office of Human Research Protections, and by departments at Purdue 
University responsible for regulatory and research oversight. All records will be kept 
confidential in locked cabinets/rooms for at least three years and after the close of the 
study. The data will be kept indefinitely and may be used for future studies. All records, 
data, and specimen will only be available to the principle investigator or his designee for 
analysis purposes.   
 
Voluntary Nature of Participation 
You do not have to participate in this study.  If you agree to participate you can withdraw 
your participation at any time without penalty. 
 
Human Subject Statement: 
If you have any questions about this research project, you can contact Professor Wayne W. 
Campbell at (765) 494-8236. If you have concerns about the treatment of research 
participants, you can contact the Institutional Review Board at Purdue University, Ernest C. 
Young Hall, Room 1032, 155 S. Grant St., West Lafayette, IN 47907-2114. The phone 
number for the Board is (765) 494-5942.  The email address is irb@purdue.edu. 
 
Documentation of Informed Consent 
I have had the opportunity to read this consent form and have the research study explained.  
I have had the opportunity to ask questions about the research project and my questions 
have been answered.  I am prepared to participate in the research project described above.  I 
will receive a copy of this consent form after I sign it.   
 
Participant Consent for Part 1 of our research: 
 
_________________________________                ___________________ 
Participant’s Signature                                                  Date 
 
_________________________________                ___________________ 
Printed Name                                                                   Date 
  
_________________________________                ___________________ 
Researcher’s Signature                                                  Date 
 
Participant Consent for Part 2 of our research (to be signed after completion of Part 1): 
 
_________________________________                ___________________ 
Participant’s Signature                                                  Date 
 
_________________________________                ___________________ 
Printed Name                                                                   Date 
  
_________________________________                ___________________ 
Researcher’s Signature                                                  Date 
 
 





 I agree to allow the use of my data and/or specimens collected during this research 
project to be used for future research that is unrelated to this study. 
 
______________________________                   __________________                       
Participant’s Signature                                               Date 
          
 I request my data and/or specimens collected during this research project to NOT 
be used for any future research that is unrelated to this study. 
 
___________________________                         __________________                                       










Appendix 4: Physician Clearance Form 
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Physician Clearance Form 
 
To Whom It May Concern: 
Patient, ______________________, has expressed interest in participating in a two part research 
study being conducted at University Place Senior Community. The study is being conducted 
by Professor Wayne Campbell in the Department of Nutrition Science at Purdue University.  
Part 1.) The purpose of the this study is to determine the metabolic effects of using low 
intensity exercise to represent the recreational lifestyle of adults 65yrs and older. 
Part 2.) The purpose of this study is to investgate the effects of a normal or high dietary 
protein intake (supplemented through a nutritional shake) on muscle function in adults 
65yrs and older. We are also investigating chronic fatigue in this population. 
During the study the following parameters will be measured: 
Resting Metabolic Rate  Blood Lipids  Blood Glucose  Body Wt  Dietary 
Intake  
Body Composition (fat and lean mass)  Blood Clinical Chemistry Panel (including kidney& liver 
functions)  
Physical Function test 
  
Energy Expenditure during low intensity exercise using a Stationary Cycle: 
Each participant will sit on a stationary cycle and pedal against very light to moderate 
resistance for up 16 minutes. 
Heart rate and preceived exertion will be monitored. As well, medical emergency services 
are available at University Place Senior Community if needed. 
Cycle protocol will include the following: 
A 2 minute warm up period at 0 (very light) resistance, 4 minutes of cycling at 0 (very 
light) resistance , 4 minutes of cycling at 10(light)  watts of resistance, 4 minutes of cycling 
at 20 (moderate) watts of resistance, and  a 2 minute cool down period at 0 (very light) 
watts resistance. 
 
The exclusion criteria are as follows: 
 Age < 65 years 
 Diagnosis of diabetes mellitus. 
 Post myocardial infarction (MI) or coronary artery bypass graft (CABG) 
surgery within 16 weeks 
 Post percutaneous transluminal coronary angioplasty  (PTCA) within 4 
weeks. 
 Acute upper respiratory infection, symptoms suggestive of cardiovascular 
disease and symptoms suggestive of acute congestive heart failure.  
 Uncontrolled hypertension at rest (systolic blood pressure greater than or equal 
to 160 mm Hg and or diastolic blood pressure greater than or equal to 100 mm 
Hg). 
 Lower extremity conditions (such as osteoarthritis or peripheral vascular 
disease), which preclude the subject from peddling a cycle at 20 watts. 
 Cognitive conditions or limitations that preclude the subject from being able to 
understand comprehend or interpret instructions, fatigue or symptoms. 
 Routine use of supplemental oxygen during rest or exercise. 




This study has the approval of the Institutional Review Board at Purdue University. As part 
of the protocol, physicians’ clearance is required. Please sign and date this form if you agree 
that this patient is suitable to participate in this study. If you need more information or 
have any question regarding this study please call.  













I have reviewed the information and in my professional opinion, the described study 




_____________________           __________                      _____________________________________________ 
Physician Name  Date   Physician Name (Printed) 
 
You may return this form by fax to our office of Nutrition Science at Purdue 













Department of Nutrition Science 
Wayne W. Campbell, Ph.D. 
 
MEDICAL HISTORY QUESTIONNAIRE 
 
The following questions are designed to obtain a thorough preliminary medical history.  
The information you provide will help us to make the best determination about your 
eligibility for a particular study.  Please answer all questions and provide as much 
information as you possibly can.  This questionnaire, as well as any other medical 
information you provide will be kept confidential and will not be shared with any 
unauthorized person or organization unless you specifically request us to do so. 
 
 
Name:  ________________________________ 
 
Street Address: _________________________________ 
 
City, State, Zip: _________________________________ 
 
Telephone number:  Home (     )__________  Work (     )______________ 
 
Date of Birth: __________ Age: _____  
           mm-dd-yy 
 
Sex: M _____  F _____ 
 
Height _____     Weight _____ 
   
 




      _________________________________________________________   
 
Last grade completed in elementary or high school: ____________ 
 
Education completed since leaving elementary or high school: 
 _____ None 
 _____ Vocational School 
 _____ Community or Junior College 
 _____ Four Year College 
 _____ Graduate School 
 _____ Professional School 
 
Occupation 









 _____ Married  _____ Single, never married 
 _____ Divorced            _____ Separated 




 _____ Alone 
 _____ With family member(s) 
 _____ With non-family members(s) 
 




Race   
 
____Caucasian (white)                    ____Hispanic 
____ African American                     ____American Indian 
____ Asian/Pacific Islander             ____Other, please indicate 
 
Personal Health History 
 
Have you ever been hospitalized or had surgery?     Yes _____     No _____ 
 
Please list all hospitalizations and surgeries to the best of your recollection 
 
Hospitalized for      Age when  














Are you allergic, sensitive or intolerant of any foods or medications? Yes___  No___ 







Are you currently seeing a doctor or other health care provider for any reason? 
 
 Yes _____     No _____     
If yes, please explain: ____________________________________________________ 
_____________________________________________________________________  
 




Alteration of your ability to remember   Yes _____     No _____ 
 
Recurring headaches     Yes _____     No _____ 
 
Recent changes in your vision    Yes _____     No _____ 
 
Numbness of an arm or leg    Yes _____     No _____ 
 
Weakness of an arm or leg    Yes _____     No _____ 
 
Difficulty in speaking or slurred speech   Yes _____     No _____ 
 
Fainting or dizziness     Yes _____     No _____ 
 
Difficulty in walking (staggering)    Yes _____     No _____ 
 
Shortness of breath                 Yes _____     No _____ 
 
Lung or Respiratory Disease    Yes _____     No _____ 
 
Rheumatism or arthritis     Yes _____     No _____ 
 
Pain in joints      Yes _____     No _____ 
 
Osteoporosis      Yes _____     No _____ 
 
Osteopenia      Yes _____     No _____ 
 
Heart disease      Yes _____     No _____ 
 
Epilepsy      Yes _____     No _____ 
 
Tumors       Yes _____     No _____ 
 
Mental illness      Yes _____     No _____ 
 
Bleeding or clotting disorders    Yes _____     No _____ 
 
Risk for infectious diseases    Yes _____     No _____ 
(AIDS, IV drug use, blood transfusions, hemophilia, hepatitis) 
 
Skin:  rashes, lumps, moles, itching, eczema  Yes _____     No _____ 
 
Nose, sinuses:  frequent colds, sinus trouble  Yes _____     No _____ 
nose-bleeds, deviated septum 
 
Neck lumps, swollen glands, pain or stiffness  Yes _____     No _____ 
 
Breasts:  lumps, nipple discharge, pain   Yes _____     No _____ 
or discomfort 
 For women:  Date of last mammogram ___________ 
 
High blood cholesterol     Yes _____     No _____ 




Stomach:  chronic indigestion, ulcer, hiatal hernia, Yes _____     No _____ 
   heartburn, trouble swallowing, vomiting. 
 
Intestine:  constipation, diarrhea, change in bowel Yes _____     No _____ 
habits, irritable bowel disorder, colitis, polyps. 
 
Rectum:  hemorrhoids, bleeding, polyps   Yes _____     No _____ 
 
Liver, gallblader:  hepatitis, gallstones   Yes _____     No _____ 
 
Urinary:  frequent urination, urgency, burning,  Yes _____     No _____ 
pain, blood in urine, infection, kidney stones 
 
Incontinence: Loss of bladder or rectal control  Yes ______   No _____ 
 
Do you use adult undergarment products 
 such as Depends?     Yes _____     No _____ 
  
Have you ever had any form of cancer, skin or other? 
 
 Yes _____     No _____     If yes, what kind:  ______________________________ 
 
Do you have diabetes mellitus (high blood sugar)? 
 
 Yes _____     No _____ 
 
 If yes, when and what kind of treatment did/do you receive: 
 
 Insulin _____      Diet _____     Pills _____     No treatment _____ 
 
 
Is there a family history of diabetes mellitus?   
Yes _____     No _____ 
 
Have you ever had or been told that you had high blood pressure? 
 
 Yes _____     No _____ 
 





Do you have any chronic illnesses? 
 
 Yes _____     No _____   
  
If yes, please explain: 
________________________________________________________________________ 
 
Do you have any problems with constipation or diarrhea? 
Yes _____     No _____ 
  






Have you ever been treated for an eating disorder? 
Yes  _____   No _____ 
 
If yes, when and what type?  _________________________________________________ 
 
 
List all the prescribed medications you are currently taking: 
 






List all the over-the-counter Physician recommended medications you are currently taking: 
 







List all the over-the-counter medications you are currently taking: 
 







Would you be willing to have your Physician give written approval for you to discontinue only your 
Physician recommended and self-prescribed medications for the duration of the study? 
 








Volunteer Name    Date 
 
 






For Females Only 
 




If yes, is your cycle regular?   Yes _____ No _____ 
 
What is the typical length of your menstrual cycle?   ______ days 
 
What is the typical length between menstrual periods?  ______ days 
 
When was your last menstruation?  __________________________ 
 
Do you or have you ever had menstrual problems, vaginal discharge, irregular bleeding, sexually 
transmitted illness. 
 Yes _____     No _____    
 
If yes, please explain: ____________________________________________________ 
 
Are you sexually active?  Yes _____ No _____ 
 
If yes, what type of contraceptives do you use? _________________________________ 
 
 
Age of menopause if applicable:  ________________ 
 
Type of menopause:     _____ natural      _____surgical     ______ other 
 
Estrogen replacement: Yes _____     No _____      
 




Last PAP smear:   ______________________________ 
Number of pregnancies:  ______________________________ 
Number of births:   ______________________________ 
Type of delivery:   ______________________________ 
Your age at time of birth (s):       ______________________________ 
Date of Hysterectomy (if applicable): __________________________ 




Are you currently taking any vitamins, minerals or health food supplements at least once per week on a 
regular basis?     Yes _____     No _____   If yes, please describe: 
 





Would you be willing to stop your vitamins, minerals or health food supplements if needed while 
participating in a study?     Yes _____     No _____ 
 
Are you currently following a special diet (i.e., vegetarian, diabetic, low fat, lactose free)? 
 
 Yes _____     No _____     If yes, what kind? ______________________________ 
  




If accepted for a study, are you willing to follow a diet that may vary from your current food intake?  
Yes _____     No _____ 
 
Have you had a weight loss or gain in the last 6 months? Yes _____     No _____ 
 
 If yes, how much?     _____lbs.    Gain _____     Loss _____ (check one) 
 
How do you describe your appetite?               Poor _____     Fair _____     Good _____ 
 
When required during the study, would you be willing and able to eat only the items provided by the 
Nutrition Laboratory, Purdue University? 
 
 Yes _____     No _____ 
 
Do you have problems eating high-fat foods?  Yes _____     No _____ 
 
Do you have any food allergies/intolerance?   Yes _____     No _____ 
 





Do you drink caffeinated beverages? (coffee, tea, soda)  Yes _____  No _____ 
 
If yes, how many caffeinated beverages do you drink in an average day?  ______/day 
 
If required during a study, would giving up caffeine cause any problems for you? 
 
 Yes _____     No _____ 
 
Do you drink alcoholic beverages?  Yes _____     No _____ 
 
If yes, how many alcoholic beverages do you consume in an average week? ______/wk 
 
Can you forego drinking  alcoholic beverages for the duration of a research study? 
 
 Yes _____     No _____ 
 
Do you have a problem drinking milk or eating dairy products? 
 
 Yes _____     No _____ 




How many meals to you typically eat in a day?  ______________ 
 
Please list the typical times that you eat throughout the day (meal #1 is the first meal of the day; only list 
the times for the meals that you eat): 
 
Meal #1:  ___________ 
 




Meal #3:  ___________ 
 
Meal #4:  ___________ 
 
Meal #5:  ___________ 
 
Meal #6:  ___________ 
 




What kind of work are you engaged in?  ______________________________________ 
 




In terms of physical demands, how would you rate your position? 
 
 very active     active     slightly active     sedentary 
 
In which of the following positions do you spend most of your time at work? 
 
 sitting     sitting and standing     walking and standing 
 
About how much time on the job do you spend sitting? 
 
 all     more than 1/2     about 1/2     less than 1/2     almost none 
 
Do you lift and carry heavy things in your work?     frequently     sometimes     infrequently 
 
Do you take walks in good weather?  frequently     sometimes     infrequently 
 
Do you do manual work at home (e.g., painting, repairing, etc.) 
 
 frequently     sometimes     infrequently 
 
Do you mow your lawn or work in your garden?     frequently     sometimes     infrequently 
 
Do you take part in sports during their season?      frequently     sometimes     infrequently 
 





In the past, were you a regular sport or exercise participant? 
 
 frequently     sometimes     infrequently 
 
When and why did you cease participating? 
 
 Approximate date: __________________ 




Do you have any condition that would prevent you from being physically active? 
 Yes _____     No _____ 




Do you smoke cigarettes at present?   Yes _____     No _____ 
 
 If yes, how many packs per day?   less than 1/2 pack 
        1/2 to 1 pack 
        1 to 2 packs 
        more than 2 packs 
 
 Do you inhale?      Yes _____     No _____ 
 
 How long have you been smoking?  less than 1 year 
        1 to 5 years 
        more than 5 years 
 
Did you smoke cigarettes in the past and quit permanently?Yes _____     No _____ 
 
If yes, how many packs per day did you smoke?          less than 1/2 pack 
        1/2 to 1 pack 
        1 to 2 packs 
        more than 2 packs 
 Did you inhale?         Yes _____     No _____ 
 
 When did you quit?     less than 1 year 
        1 to 5 years 
        more than 5 years 
 
Do you smoke cigars at the present?   Yes _____     No _____ 
 
 If yes, how many cigars per day?   less than 2 
        2 to 5 
        more than 5 
 
Did you smoke cigars in the past and quit permanently? Yes _____     No _____ 
 
Do you smoke a pipe at present?   Yes _____     No _____ 
 
 If yes, how many pipefulls do you smoke per day? less than 2 
        2 to 5 
        more than 5 
 















Subject Name: _______________________________________ 
 
Date: ___________________  Time: _____________________ 
 
 
























Have you experienced any symptoms of illness including, but not limited to, dizziness, 
nausea, lightheadedness, fatigue, gastrointestinal distress, diarrhea, shortness of breath, 








Subject Initials: _________________________________ 











Indiana Clinical and Translational Sciences 
Institute 
                                                                                        
 
Completing Multiple Day Food Records 
General Instructions for Keeping Records 
 Please use ink and write clearly. 
 Please complete the food records for the number of days and specific days of the 
week (i.e. weekend days vs. weekdays) that were specified by the dietitian or study 
coordinator. 
 Remember to not change your eating habits. 
 Record everything you eat and drink in a 24 hour period, from midnight to midnight, 
preferably right after it’s consumed. 
 Write each food, beverage, or ingredient on a separate line. 
 Start each new day on a new page.  If you need more than one page per day, please 
mark the pages.  
 Fully describe foods & beverages, including brand names, when possible.  If the item is 
cooked, please describe how it is prepared (e.g. boiled, broiled, grilled, baked, fried, 
etc.) 
 Estimate the portion sizes of everything you consume.  Refer to page 2, “Seven Ways 
to Size up your Servings,” for help with estimating portion sizes. 
 Include items you add at the table.   List them on separate lines.  (e.g. margarine on a 
baked potato) 
 You may attach copies of recipes. 
                     














 Indicate if whole wheat, white, etc. 
 Record number, size, & portion. 
 Include sandwich condiments & additions 
(e.g. lettuce, tomato, mustard) 
Beverages 
 List the type of milk – whole, 2%, etc. 
 List whether fruit juice is fresh, frozen, 
sweetened, and if calcium fortified. 
Cereals 
 Record cooked cereal in portions of cup and 
amount eaten after cooking. 
 Record dry cereal in level portions of cup. 
 Note if milk, fruit, sugar, etc are added and 
the amounts (e.g. 1 tsp brown sugar). 
Cheese 
 Record the size in inches or weight in oz. 
 Describe fat content – skim, 1%, 2%, whole. 
 
Desserts 
 List commercial brand or 
homemade. 
 Record portion size of cakes, pies, 
and cookies by indicating thickness, 
diameter, width or length (e.g. 
brownie 2” x 2”) 
 Candy - # of pieces or size in 
ounces 
Fruits 
 Indicate if fresh, frozen, dried, or 
canned. 
 If whole, record # eaten and size (1 
apple, 3” diameter). 
Meats, Fish, Poultry 
 Record size in inches or weight in 
ounces, without bone, after cooking. 
 Indicate leanness (e.g. % fat ground 
beef). 
 Describe how meat was prepared. 
Mixed Dishes 
 Stews, soups, casseroles, meat 






3 ounces of meat is about the size and thickness of a deck of 
playing cards or an audiotape cassette. 
 
2 A medium apple or peach is about the size of a tennis ball. 
 
3 1 ounce of cheese is about the size of 4 stacked dice. 
 
4 








1 teaspoon of butter or peanut butter is about the size of the tip 
of your thumb. 
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   MEAL         PLACE          TIME                   METHOD OF 
B = Brkfast    PREPARED  CONSUMED     PREPARATION                AMOUNT  
L = Lunch      H = Home           e.g. Baked,                 & / OR SIZE 
D = Dinner    R = Restaurant                          Broiled, Fried,                                  FOODS & BEVERAGES                                      (e.g. cups, oz,      
S = Snacks     O = Other        Raw, Canned etc.                                    (Include brand names, if known)                                    tsp, Tbsp, inches) 
 
 
 
 
 
